A Phase IIIA, open, randomized study to assess immunogenicity and safety of Fluarix™/Influsplit SSW® 2010/2011 or Pandemrix™ vaccination in adults aged 18 years and above previously vaccinated with on...

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-020313-81

A Phase IIIA, open, randomized study to assess immunogenicity and safety of Fluarix™/Influsplit SSW® 2010/2011 or Pandemrix™ vaccination in adults aged 18 years and above previously vaccinated with one dose of Pandemrix™

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the humoral response in terms of haemagglutination inhibition (HI) antibodies against each influenza vaccine strain corresponding to the influenza vaccine administered, at Day 21, in subjects aged 18-60 and above 60 years.


Critère d'inclusion

  • Immunization against influenza in male and female adult subjects

Liens